# Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A

> **NCT01704508** · PHASE4 · COMPLETED · sponsor: **Bandim Health Project** · enrollment: 346 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artemether-lumefantrine
- **DRUG:** Dihydroartemisinin-piperaquine

## Key facts

- **NCT ID:** NCT01704508
- **Lead sponsor:** Bandim Health Project
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2015-10
- **Final completion:** 2016-07
- **Target enrollment:** 346 (ACTUAL)
- **Last updated:** 2021-05-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01704508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01704508, "Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01704508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*